Lachelle D. Weeks

Prediction of Risk for Myeloid Malignancy in Clonal Hematopoiesis

Lachelle D. Weeks, Abhishek Niroula, Donna Neuberg et al. · NEJM Evidence · 2023 · 265 citations · Full text

<i>TET2</i>-mutant clonal hematopoiesis and risk of gout

Mridul Agrawal, Abhishek Niroula, Pierre Cunin et al. · Blood · 2022 · 143 citations · Full text

Immunodeficiencies, Immunology, Immune Regulation +22

Clonal Hematopoiesis of Indeterminate Potential Predicts Adverse Outcomes in Patients With Atherosclerotic Cardiovascular Disease

Esra D. Gümüşer, Art Schuermans, So Mi Jemma Cho et al. · Journal of the American College of Cardiology · 2023 · 125 citations · Full text

Vascular Disease, Pathology, Hyperlipidemia +16

Removal of uracil by uracil DNA glycosylase limits pemetrexed cytotoxicity: overriding the limit with methoxyamine to inhibit base excision repair

Alina Bulgar, Lachelle D. Weeks, Y. Miao et al. · Cell Death and Disease · 2012 · 93 citations · Full text

Uracil–DNA Glycosylase Expression Determines Human Lung Cancer Cell Sensitivity to Pemetrexed

Lachelle D. Weeks, Pingfu Fu, Stanton L. Gerson · Molecular Cancer Therapeutics · 2013 · 64 citations · Full text